Skip to main content

Alligator Bioscience wins SwedenBIO Award 2016

Press Release   •   May 20, 2016 03:09 EDT

Jonas Ekstrand, Director general SwedenBIO, Marten Steen, partner Healthcap, Per Norlén, CEO Alligator Bioscience and Lars Adlersson, chairman of the Board, SwedenBIO at the ceremony Thursday evening.

The 10th annual SwedenBIO Award was awarded at a price ceremony in Stockholm, Sweden, on Thursday evening. This year’s winner is Alligator Bioscience AB, whose pioneering research and great business acumen is a source of inspiration to companies throughout the Swedish life science industry.

“A true pioneer, Alligator Bioscience has been quick to identify how new therapeutic concepts can be used to develop unique antibodies with potential to extend life for patients with late-stage cancer. Its advanced research and great business acumen has resulted in a commercial agreement of rare scope with one of the world’s largest pharmaceutical companies. Whilst still in an early development phase with elevated project risk, the commercial potential in this agreement is a source of inspiration for life science companies throughout Sweden.”

Nominees
The nominees for SwedenBIO Award 2016 were Alligator Bioscience AB, Aprea AB, CTC Clinical Trial Consultants AB, Dilafor AB, Moberg Pharma AB and Xbrane Biopharma AB.

The Award
SwedenBIO Award recognizes outstanding achievements in Swedish life science that grow awareness and interest in the industry. Beyond the formal recognition of merit and achievement, the prize winner is awarded two delegate tickets to the Nordic Life Science Days on 14-15 September, 2016 (www.nlsdays.com).

This year’s award is the 10th annual SwedenBIO Award. The prize is awarded together with HealthCap, and the previous winners are Recipharm, Orexo, Affibody, Vitrolife, Aerocrine, BioInvent, Cellavision, Medivir and Gyros.

Jury
The winner is selected by SwedenBIO’s Board of Directors: Lars Adlersson, Six Year Plan; Ulrica Slåne, AP3/The Third Swedish National Pension Fund; Sarah Fredriksson, Genovis; Jan Erneberg, GE Healthcare; Yvonne Mårtensson, independent board member and adviser; Per Samuelsson, HealthCap; Eva Sjökvist Saers, APL; Thomas Eldered, Recipharm; Magnus Björsne, AstraZeneca; and Johan Brun, Pfizer.

Contact:
Lars Adlersson, Chairman of the Board, SwedenBIO. lars.adlersson@sixyearplan.se, +46 706 666 236.

SwedenBIO helps innovative companies succeed! SwedenBIO is the national organization working for the benefit of the entire life science sector in Sweden - a member driven, private non-profit organization. The main objective is to improve and maintain industry conditions which will support prosperous growth and business development among our, today, close to 200 member companies. Our members are active in the fields of pharmaceutical, biotech, medtech and diagnostics. Our mission is to create visibility and interest for the Swedish life science and thereby support a successful life science industry. A successful industry can heal and help those patients still suffering from unmet medical needs. A successful industry creates jobs and welfare and creates opportunities for a healthier and brighter future. We’ve been successfully doing this for 10 years.

www.swedenbio.com

Comments (0)

Add comment

Comment

Agree With Privacy Policy